The bisdioxopiperazines inhibit the catalytic cycle of topoisomerase II by binding in proximity of the ATP binding site and trapping the enzyme as a closed clamp on DNA [18].
The catalytic cycle can be halted by drugs that dock into the ATP-binding pocket and prevent nucleotide binding.